Math matters: Model predicts breast cancer survival

Lisa Fratt | | Health Imaging | Medical Imaging

A crowd-source challenge showed a computational model to be highly predictive of breast cancer survival, according to results published April 17 in Science Translational Medicine.

Dimitris Anastassiou, PhD, professor of electrical engineering at Columbia University in New York City, and colleagues developed a model based on attractor metagenes associated with mitotic chromosomal instability, mesenchymal transition or lymphocyte-based immune recruitment, which are found in nearly identical form in many types of cancer. The prognostic model showed these signatures, in correct combination, could predict breast cancer survival.

“If these general cancer signatures are useful in breast cancer, as we proved in this challenge, then why not in other types of cancer as well? I think that the most significant—and exciting—implication of our work is the hope that these signatures can be used for improved diagnostic, prognostic, and eventually, therapeutic products, applicable to multiple cancers,” Anastassiou said in a press release.

He suggested that the researchers' “pan-cancer” signatures may be more accurate than existing biomarkers used in biopsies.

The model won the Sage Bionetworks/DREAM Cancer Prognosis Challenge.

Lisa Fratt

Related Content

FDA says CT scans sometimes damage implantable cardiac electronic devices
Bilingual people have more efficient brains, imaging study shows
Use of AI opportunistic screening in CT for cardiovascular disease
ChatGPT is overly worried about ED patients
Low doses of radiation still increase risk of leukemia, lymphoma and myeloma
ACR offers resources to achieve radiology AI best practices

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.